Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)
ConclusionTreatment ofBRAF V600E-mutant metastatic melanoma with dab + tram in the real-world setting was effective and safe, including the unselected population with several patients having a high tumor burden – concordant with the results of the pivotal phase 3 studies of dab + tram.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer & Oncology | Clinical Trials | Italy Health | Melanoma | Neurology | Skin Cancer | Study